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Abstract There is considerable sequence homology between 
dystrophin and utrophin, both at the protein and DNA level, and 
consequently it was assumed that their domain structures and 
functions would be similar. As more of the detailed biochemical 
and cell biological properties of these two proteins become known, 
so it becomes clear that there are subtle if not significant differ- 
ences between them. We review recent findings and present new 
hypotheses into the structural and functional properties of the 
actin-binding domain, central coiled-coil region and regulatory/ 
membrane protein-binding regions of dystrophin and utrophin. 
Key words': Utrophin; Dystrophin; Spectrin; Actin binding; 
Coiled-coil 
1. Introduction 
One of the crucial links involved in maintaining the integrity 
of the cell membrane during muscle contraction is the cytoskel- 
etal protein dystrophin. Consequently mutations or deletions 
in the dystrophin gene, located on the X-chromosome, lead to 
fragility in the muscle membrane and necrosis associated cell 
death, as typified in the X-linked myopathies Becker and Duch- 
enne muscular dystrophy [1]. Utrophin, the autosomal homo- 
logue of dystrophin, shares considerable sequence homology 
[2], suggesting that it may have similar functions and raising the 
possibility of utrophin being used as a therapeutic replacement 
for dystrophin in muscular dystrophy [3]. Dystrophin and utro- 
phin also share sequence homology with other cytoskeletal 
proteins such as the spectrins and ct-actinin with which they 
form a broad family. The overall domain structure of dystro- 
phin and utrophin is shown in Fig. lb. The NH2-terminal re- 
gions of dystrophin and utrophin bind to the actin cytoskele- 
ton, acting as the intracellular anchor whereas the COOH- 
terminal regions bind to a group of proteins anchored in the 
cell membrane (Fig. 2). These two regions are connected by a 
long, potentially flexible rod which comprises over 70% of the 
protein. The complex of proteins anchored in the membrane, 
the dystrophin/utrophin-associated proteins in turn bind to 
components of the extracellular matrix, mainly laminin. Thus 
dystrophin and utrophin form a link between the actin cytoskel- 
eton and the dystrophin/utrophin-associated protein complexes 
which can be considered to be new additions to the growing 
family of cell anchoring molecules. 
2. Actin binding domain 
Although the N H2-terminal actin binding regions in dystro- 
phin and utrophin were initially identified on the basis of se- 
quence similarity to the actin binding domain of c~-actinin, 
recent work has shown that the bacterially expressed omains 
from dystrophin and utrophin do indeed bind actin in vitro [4,5] 
and in transfected or microinjected cells [5,6]. Furthermore, in 
vitro studies have demonstrated that purified dystrophin or 
dystrophin enriched fractions also cosediment with F-actin [7 
9]. Actin binding has been demonstrated byNMR, cosedimen- 
tation and solid-phase assay, using peptides, expressed fusion 
and non-fusion proteins and native dystrophin [4,5,7 12]. 
Given the variety of techniques employed, the findings are in 
broad agreement, with binding affinities of dystrophin and 
utrophin for F-actin in the high nM to low ~M range. In one 
comparative study [5] a bacterially expressed utrophin con- 
struct was shown to bind to skeletal muscle F-actin with ~2-fold 
higher affinity than the equivalent region of dystrophin, fur- 
thermore, both dystrophin and utrophin constructs bound to 
non-muscle (platelet) F-actin with ~4-fold higher affinity than 
to skeletal muscle actin. This clear demonstration that dystro- 
phin and utrophin bind to non-muscle actin with higher affinity 
suggests that in muscle cells dystrophin binds to a cortical 
submembrane twork of non-muscle actin and not directly to 
the sarcomeric actin. Whilst deletion analysis of the actin bind- 
ing domain of dystrophin and utrophin has revealed three dis- 
tinct regions important for actin binding (called ABSI, ABS2, 
ABS3 from NH 2- to COOH-terminal respectively [5], Fig. la), 
none appears to be absolutely essential for actin binding and 
it is likely that all three contribute in some way to the overall 
actin binding 'pocket' in the tertiary structure of these proteins 
[5,8]. 
One recently discovered ifference in behaviour between the 
actin binding domains of dystrophin and utrophin, however, is 
the interaction with calmodulin. Although the bacterially ex- 
pressed actin binding domains from both dystrophin and utro- 
phin bound to calmodulin affinity columns in the presence of 
calcium [13,14], but not in the absence, only utrophin binding 
to actin was inhibited by calmodulin in a calcium-dependent 
manner [14]. Given the high degree of sequence conservation 
in this region in these two proteins, the reasons for this differ- 
ence in behaviour may have to await the elucidation of their 
tertiary structures. 
3. Coiled-coil region 
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The central region of the dystrophin and utrophin molecule 
consists of a series of weakly repeating units o f -  110 amino acids 
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Fig. 1. Domain structure of Dystrophin and Utrophin. All diagrams are shown with the NH2-terminus at the left. Numbers refer to amino acid residues 
delimiting the domains or regions in the respective sequences, dystrophin on top and utrophin on the bottom. (a) Schematic view of the actin binding 
domains of dystrophin and utrophin with principal regions haded. ABS1 3 represent the major actin binding regions and CaM represents a putative 
calmodulin binding site. (b) Representation f the whole dystrophin and utrophin domain structure indicating the principal domains. A, actin binding; 
WW, WW or WWP domain; Ca Ca, calcium binding EF-hands; Cys, cysteine rich; H1 and H2, helices 1 and 2, respectively. The central coiled coil 
regions comprising 24 and 22 repeats indystrophin and utrophin respectively are unlabelled; *above utrophin indicate the relative positions of missing 
repeats 15 and 19. (c) Schematic view of the COOH-terminal domains of dystrophin and utrophin with principal regions haded. Nomenclature is
as above, the shaded bars above the dystrophin sequence r present the regions involved in binding the dystrophin-associated proteins fl-dystroglycan 
and syntrophin. 
with similarity to the coiled-coil repeats of spectrin [15,16]. 
Analysis of the dystrophin sequence revealed 24 or 25 repeats 
separated by 4 proline-rich inge regions [17,18], similarly utro- 
phin is thought o contain 22 repeats and two hinges, see below. 
Dotplots reveal, that compared to dystrophin, utrophin is miss- 
ing repeats 15 and 19 (conversely dystrophin could have gained 
repeats at these positions). Cross et al. [18] proposed that the 
structure of the coiled coil repeat would comprise one short 
helix and the NH 2- and COOH-terminal halves of separate 
flanking long helices. CD analysis of an expressed ystrophin 
repeat [19] and the recent solution of the crystal structure of a 
spectrin repeat [20] would agree with this model. This arrange- 
ment of nested repeats and hinges would suggest ahighly elastic 
and flexible molecule. It should be stressed however, that the 
conservation between repeat units in dystrophin and utrophin 
is much weaker than that seen in spectrin, particularly when 
one compares the sequence alignments, and the numbers of 
conserved residues and insertions between the repeats of ~- and 
,8-spectrin with respect to dystrophin and utrophin (see Fig 3). 
There are more conserved residues in the aligned spectrin 
sequences than in dystrophin and utrophin (compare the over- 
all amount ofcolour in Fig. 3a vs. 3b). The lengths of the helices 
in the spectrins are more consistent and well defined and con- 
tain considerably fewer insertions than do those in dystrophin 
and utrophin. Compared to the spectrins the B helices in 
dystrophin and utrophin are less regular, repeats 10 and 14 in 
dystrophin and 14 in utrophin are truncated, there are large 
insertions after the B helix in repeats 23/21 of dystrophin/utro- 
phin and large insertions within the A helix in repeats 3, 15 and 
19 of dystrophin and 3, 13, and 17 of utrophin. The insertions 
in the A helix (helix C in one repeat is continuous with helix 
A in the next) would be especially unfavourable for antiparallel 
dimer formation due to the insertions putting the helices out of 
register. ~- and fl-spectrin are known to form anti-parallel 
dimers, so surface residues hould be conserved in the dimer 
interface. There are 21 extra residues conserved in each spectrin 
repeat and they map to one external face of the domain struc- 
ture, consisting of helix A and half of helix B: therefore this 
region is likely to be the dimer interface. The conservation 
pattern suggests that the NH2-terminus of helix A packs in a 
groove formed by the COOH-terminus of helix A' and the 
NH2-terminus of helix B' in the apposing dimer. By contrast, 
all of the conserved residues in dystrophin and utrophin map 
exclusively to core or interface positions with none available to 
form a surface for dimer interface as in spectrin. 
Electron micrographs of rotary shadowed ystrophin mole- 
cules have revealed a heterogeneous population comprising 
mostly monomers, but also some dimers, end to end and side 
by side, and higher order structures [21,22]. Recently, however, 
Sato et al. suggested that the dumbbell shaped structures een 
in their micrographs may have been collagen VI contaminants 
and not dystrophin [23]. Ervasti et al. [24] claimed that alkali 
treated dystrophin (which by their own admission was not 
completely pure) sedimented ata size consistent with a dystro- 
phin dimer, though no data were presented. The lack of se- 
quence conservation among the surface residues of the dystro- 
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Fig. 2. A representation f the organisation of dystrophin and utrophin and associated proteins in a hypothetical cell. Ad, adhalin; 35, 35 kDa 
dystrophin- (utrophin-)associated glycoprotein (DAG); 25, 25 kDa dystrophin- (utrophin-)associated protein (DAP); fl,/3-dystroglycan; a, ~- 
dystroglycan; syn, syntrophin. 
phin and utrophin coiled coil regions and the insertion of loops 
between some of these regions argues trongly against side by 
side dimerisation along the whole length of these molecules. It
is possible that dystrophin and utrophin may dimerise in an end 
to end arrangement via the COOH-terminal coiled coil regions 
[25] or possibly by a staggered overlap involving a short region 
of dimerisation i the coiled coil region. There is at present, 
however, no direct biochemical evidence to support any of 
these hypotheses. 
4. Regulatory/membrane protein-binding regions 
The carboxy-terminal regions of dystrophin and utrophin 
present a complex arrangement of domains (Fig. lc) whose 
functions are only just beginning to be elucidated. The COOH- 
terminus is clearly involved in binding to the membrane 
glycoprotein complex [26,27] and possibly to other proteins. 
These interactions may be regulated by other domains within 
the COOH-terminus: namely the WW/WWP domain [28,29] or 
the Ca2+-binding domain [16], alternatively these two regula- 
tory domains may be involved in other as yet uncharacterised 
functions. 
4.1. Membrane protein-binding regions 
A full discussion of the dystrophin- and utrophin-associated 
proteins is beyond the scope of this short article, and readers 
are directed to a recent review [30]. Two of these proteins, 
however are pertinent to this discussion: the 43 kDa transmem- 
(Figure see pp. 4 and 5) 
Fig. 3. Alignment of speetrin-type triple-helical repeats in a-spectrin, fl-spectrin, dystrophin and utrophin, colour coded to highlight conserved 
features. (a) Repeats from a- and fl-spectrins. *Denotes the partial terminal repeats thought to mediate nd-to-end association ofa- and fl-spectrin. 
Gaps in unconserved loops have been minimised and deleted sequences are recorded within angle brackets: (n). Comment lines below the sequence 
annotate the 3 a-helices; Spc v Dmd, the positions howing reater conservation i  spectrins (S) or in dystrophin/utrophin (D); heptad, the helical 
heptad periodicity; helices, helix name for identification purposes, it should be noted that helix C is continuous with helix A in the following repeat; 
Spc no., residue number as for the solved structure of a Drosophila repeat [20]. All G (orange) and P (yellow) residues are coloured. Other colouring 
is by conserved property in >55% of any column: uncoloured residues lack a sufficiently conserved property. Blue, hydrophobic; light blue, partially 
hydrophobic; red and pink, positive; purple, negative; green, hydrophilic. The figure was prepared with the GDE alignment editor (S. Smith, Harvard) 
and COLORMASK (J. Thompson, EMBL). (b) Repeats from dystrophin and utrophin displayed as in (a). *Indicates aberrant repeats with truncated 
helices. 
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brane glycoprotein, fl-dystroglycan [31] and a heterologous 
group of 58 59 kDa intracellular proteins [32-34] known as the 
syntrophins. Recent elegant studies from Ozawa's group 
[27,35,36] have delineated the regions in dystrophin involved in 
the binding of fl-dystroglycan d the a 1- and fl 1-syntrophins; 
they are the cysteine-rich region and first helical region (H1) of 
the COOH-terminus (Fig. lc). fl-dystroglycan binds tightly to 
the proximal part of the cysteine-rich region even overlapping 
into the WW/WWP domain, with a weaker interaction at the 
distal end of this region [36]. ~l-syntrophin binds to a region 
between the end of the cysteine-rich region and start of the first 
COOH-terminal helical region, and fll-syntrophin binds to the 
first helical region itself [27]. 
It has been demonstrated, using the yeast wo-hybrid system, 
that this first helical region of dystrophin interacted with the 
fast skeletal muscle isoform of troponin T [37]. It is difficult, 
however, to reconcile this latter finding in terms of our current 
understanding of the organisation of dystrophin and the 
dystrophin-associated proteins in the submembrane cytoskele- 
ton of muscle and non-muscle cells. 
We have proposed [25] that the helical regions at the COOH- 
termini of dystrophin and utrophin may be involved in protein- 
protein interactions. Analysis of these helical regions reveals a 
propensity for parallel dimeric oiled-coil nteractions, possibly 
involved in dimerisation of dystrophin or utrophin molecules, 
or interaction with other proteins. Interestingly, using the 
Lupas algorithm [38] none of the syntrophins are predicted to 
contain regions that will form coiled coils, suggesting an alter- 
native mode of binding to helix 1 of dystrophin/utrophin. Nev- 
ertheless, if syntrophins do bind to the first helical region, there 
is still the potential for other protein-protein i teractions with 
the second helix H2 (Figs. lc, 2). 
4.2. Regulatory regions 
Analysing the sequences of the two potential EF-hand Ca 2+- 
binding motifs identified in the dystrophin and utrophin se- 
quences [2,16] suggests, that the absence of crucial amino acids 
in the co-ordinating positions within the binding loops would 
mean that these sites should not bind calcium. Recent structural 
information has revealed, however, that despite the apparent 
absence of essential amino acids in the Ca2+-coordinating posi- 
tions, the scallop myosin essential light chain is still able to bind 
calcium. In this case the missing ligating side chains are contrib- 
uted by the other light chain and the myosin heavy chain which 
interact o form a functional binding loop [39]. These observa- 
tions may explain why Milner et al. [40] were able to detect 
calcium binding in a GST-fusion construct comprising residues 
3,107 3,400 of dystrophin, whereas Ervasti and Campbell 
failed to detect calcium binding in [45Ca] gel-overlays of blotted 
whole dystrophin [7], possibly due to the inability of whole 
dystrophin to re-fold correctly after blotting. Furthermore, 
calmodulin overlays with whole dystrophin failed to detect 
calmodulin binding [7] despite positive results being obtained 
with discrete expressed omains [13,14]. Negative results in 
gel-overlay experiments herefore, cannot necessarily be con- 
strued as evidence of lack of function. Given the degree of 
conservation i the EF-hand regions of dystrophin and utro- 
phin it is quite likely that utrophin also binds calcium. The 
precise function, structural or regulatory, of calcium binding in 
dystrophin and utrophin is not known; it may regulate binding 
to the membrane-associated protein complex, it may even reg- 
ulate actin binding as in ~z-actinin and spectrin [14] or it may 
be involved purely in a structural role (as a Mg2+/Ca 2+ binding 
site). Further experiments are needed to clarify these points. 
The most recently identified omain within dystrophin is the 
WW or WWP domain [28,29], so called because of two con- 
served tryptophan (single letter code, W) and a proline (P) 
residues flanking the ~30 amino acid region. It has been pro- 
posed that the WW/WWP domain is somehow involved in 
protein-protein interactions, possibly fulfilling a role similar to 
the Src homology (SH2, SH3) or pleckstrin homology domains. 
The WW/WWP domain appears to be inside the region in 
dystrophin required for fl-dystroglycan binding [27,36] and as 
such may be involved in that interaction, further analyses are 
required to substantiate hese suggestions. 
Structural and functional analyses are beginning to shed light 
on the roles of dystrophin and utrophin in the cytoskeleton. It 
is clear however, that there is still a long way to go before we 
can confidently fill in the missing link. 
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